Solitary intestinal neurofibroma with no associated systemic syndromes causing intussusception: Case report and literature review  by Al-Harake, Ali et al.
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INTRODUCTION:  The  isolated  presence  of  neuroﬁbromatous  lesions  in the  gastrointestinal  tract,  with  no
associated  systemic  syndromes,  is  a rarely  reported  clinical  entity.
PRESENTATION OF  CASE:  A  48-year-old  lady,  with  no  history  of  neuroﬁbromatosis  or other  systemic  dis-
ease,  presented  with  small  bowel  obstruction  secondary  to an  ileo-ileal  intussusception  induced  by  an
isolated  ileal  neuroﬁbromatous  mass.  The  patient  underwent  a segmental  enterectomy  and  after  a  smooth
recovery,  she  was  put  on a  long-term  follow-up  schedule.euroﬁbroma
ntussusception
mall intestinal tumour
ntestinal  obstruction
DISCUSSION: This  article  presents  a  review  of  the  literature  of  this  area  clinical  entity.  Very  few  reports  of
gastrointestinal  isolated  neuroﬁbromas  could  be  found.  Similarly,  extra-digestive  isolated  lesions  have
been  rarely  reported.
CONCLUSION:  Isolated  ileal  neuroﬁbroma  is a  rare pathological  entity.  The  clinical  signiﬁcance  of such  a
diagnosis  lies  mainly  in the need  of  further  follow  up of  these  patients  as  the  bowel  involvement  could
be  the  ﬁrst  manifestation  of  neuroﬁbromatosis  type  1  or multiple  endocrine  neoplasia  type  2b.
gical © 2013 Sur
. Introduction
Neuroﬁbromatous proliferations in the gastrointestinal tract,
n general, and the small intestines, in particular, have well been
escribed in neuroﬁbromatosis type 1. However, the isolated pres-
nce of such lesions in the intestines with no evidence of systemic
isease is a rarely reported clinical entity. Herein, we  report the case
f an isolated ileal neuroﬁbroma in a middle-aged lady, presenting
s an ileo-ileal intussusception. A review of the medical literature
n this rare entity follows.
.  Report of a case
.1.  History
A 48-year-old lady presented to our hospital with a 10-day his-
ory of intermittent, colicky, epigastric abdominal pain radiating
ccasionally to the whole abdomen, exacerbated by food intake.
he is known to suffer from peptic ulcer disease (PUD) with a small,
liding-type, hiatal hernia. She has undergone laparoscopic chole-
ystectomy and appendicectomy several years before and, upon
resentation, was on no medications. After normal chest X-ray,
bdominal computed tomography (CT) scan and laboratory studies,
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an upper gastrointestinal endoscopic exploration showed severe,
diffuse gastritis with antral and prepyloric erosions. A gastric biopsy
showed non-atrophic glands and moderate chronic inﬂammation
with few crypts showing Helicobacter pylori (H. pylori) organisms,
suggesting type B gastritis.
So,  the patient was  diagnosed as suffering from severe gas-
tritis and was  started on H. pylori eradication therapy; however,
she showed no symptomatic improvement. Three days later, while
still at the hospital, the patient’s abdominal pain worsened and
she started to develop global abdominal distension with clini-
cal deterioration suggesting a distal gastrointestinal obstruction.
An erect abdominal X-ray showed multiple air/ﬂuid levels. Feacu-
lent material drained upon inserting a naso-gastric tube. A repeat,
urgent abdominal CT scan (Fig. 1) showed severe distension of the
stomach, duodenum, jejunum and ileum with ﬂuid stasis due to
intestinal intussusception at the level of the terminal ileum caused
by an ileal tumour resulting in this obstructive syndrome.
Thence, the surgery team was  consulted and surgical explo-
ration was  decided in view of the patient’s presentation and
worsening clinical condition. During the laparotomy, around 500 cc
of  clear ascitic ﬂuid was  drained and largely distended jejunal and
ileal loops were encountered. Upon running the small bowels, an
ileo-ileal intussusception (Fig. 2) at some 60 cm from the ileoce-
cal valve was  identiﬁed and reduced and an intra-luminal mass
could easily be palpated, the mesentery looked normal with no evi-
Open access under CC BY-NC-ND license. dence of vascular compromise. No lymph nodes or other palpable
intra-luminal masses could be discovered. A segmental entrectomy,
including about 10 cm of the ileum from either side of the mass
along with the associated mesentery was  performed. Continuity of
Y-NC-ND license. 
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6ig. 1. Computed tomographic scan image. Computed tomographic scan image
howing  the site of ileal intussusception (target sign) and grossly dilated small bowel
oops.
he bowels was re-established by a hand-sewn, side-to-side anas-
omosis.
.2. Pathology
Macroscopically, the ileal segment measured 24 cm ×
 cm × 5 cm.  When the bowel loop was incised, a well-delineated,
ntra-luminal mass arising from the bowel wall was identiﬁed
easuring about 3.5 cm × 3 cm × 3 cm,  this mass was  spherical and
edunculated, having a smooth surface with a hard consistency;
rossly, no hard or inﬁltrative areas related to the mass could be
dentiﬁed (Fig. 3). The pathology report revealed a normal intesti-
al wall except for a central, well-delineated, ﬁbrous, spindle-cell
eoplasm in different planes consistent with a neuroﬁbroma.
ig. 2. Intra operative picture. The site of the ileo-ileal intussusception at some
0  cm proximal to the ileo-cecal valve.Fig. 3. Macroscopic view. A macroscopic view of the ileal neuroﬁbroma.
2.3. Outcome
Following the pathological diagnosis of an isolated small
bowel neuroﬁbroma, a thorough physical examination of the
patient failed to reveal any evidence of neuroﬁbromatosis, mul-
tiple endocrine neoplasia or other syndromes. She had a smooth
post-operative course. Food intake was initiated on the fourth
post-operative day and the patient left the hospital on the sev-
enth post-operative day. After discussing the condition with the
patient, a follow-up schedule, consisting of 6-monthly visits, was
planned with her to diagnose any emerging signs of neuroﬁbro-
matosis or multiple endocrine neoplasia in the future. Three weeks
post-operatively, a colonoscopy was performed that showed to be
normal, ruling out any colonic polyps.
3. Discussion
Neuroﬁbromas are benign neoplasms consisting of prolifera-
tions of all the elements in the peripheral nerves, including neurites
and ﬁbroblasts, and the predominance of elongated, serpentine
Schwann cells, with their slender, spindle-shaped nuclei. Typi-
cally, these components are dispersed in a disorderly pattern,
often in a loose, myxoid stroma.1,2 Neuroﬁbromas are usually mul-
tiple upon presentation and are usually part of two  autosomal
dominant disorders with variable penetrance: neuroﬁbromatosis
type 1 (NF1, von Recklinghausen’s disease) and neuroﬁbromato-
sis type 2 (NF2, central or bilateral acoustic neuroﬁbromatosis).3
However, approximately half the cases of NF1 and NF2 arise
from new mutations.4 These disease entities have variable clin-
ical expressions with manifestations involving the skin, nervous
system, eyes, bones, gastrointestinal tract (GIT), vascular system
and other body parts.3 While NF1 is more common than NF2,
NF1 is characterised by cutaneous manifestations as café-au-lait
spots and axillary freckling along with a large number of ner-
vous system tumours. On the other hand, the hallmark of NF2,
and as its name suggests, is bilateral vestibular schwannomas
in over 90% of patients, in addition to other nervous system
tumours.4
Gastrointestinal involvement in neuroﬁbromatosis is an uncom-
mon entity.5 While the neuroﬁbromas do not typically affect the
gastrointestinal tract in NF2,5 these lesions are the most com-
mon abdominal neoplasms encountered in NF1, affecting the GIT in
10–25% of patients.6 Ganglioneuromatosis and neuroﬁbromatosis
are the pathologic forms of gastrointestinal involvement.7 Neu-
roﬁbromas of the GIT are usually originating from either the
 –  O
al of S
p
b
l
p
h
p
w
f
t
C
o
r
i
a
o
c
a
r
n
p
s
n
a
o
t
o
d
t
2
o
d
t
s
i
t
t
a
a
i
o
i
t
t
o
c
i
i
c
p
e
Y
c
w
o
e
d
b
i
a
tCASE  REPORT
A. Al-Harake et al. / International Journ
lexus of Meissner in the submucosa or the plexus of Auer-
ach in the muscularis propria or even from the serosa.8,9 These
esions are often sessile and wide-based but also pedunculated
olyps have been observed.8 Ganglioneuromatosis, on the other
and, refers to extended hyperplasia and hypertrophy of the nerve
lexuses and ganglion cells in the mucosa or throughout the bowel
all,3 this may  lead to mural thickening and eventually stricture
ormation.6 Similar lesions could be found within the bowel mesen-
ery, these lesions may  be grossly mistaken with lymph nodes.6
haracteristic neuroﬁbromas have been found in the GIT in 11%
f patients with NF1,10 according to some reports. Multiple neu-
oﬁbromas are more often discovered in the jejunum, stomach,
leum, duodenum and colon according to the frequency of the their
ppearance.3,10 To note, further, that NF1 is also associated with the
ccurrence of other neoplasms that involve the GIT, including car-
inoids, somatostatinomas, leiomyomas, sarcomas and pancreatic
denocarcinomas.7,10 Moreover, neuroﬁbromas and ganglioneu-
omas of the GIT have also been reported in multiple endocrine
eoplasia type 2b (MEN 2b), juvenile and adenomatous colonic
olyposis.11
Consequently, the presence of gastrointestinal neuroﬁbromato-
is in association with NF1, and probably other syndromes, is
ot a rare clinical entity. However, it is rarely encountered as
 separate pathologic entity8 and reports of isolated ﬁndings
f neuroﬁbromatous proliferations in patients with no addi-
ional clinical evidence of neurocutaneous, intestinal polyposis
r multiple endocrine neoplasia syndromes have been rarely
ocumented.12 In these settings, isolated intestinal neuroﬁbroma-
ous proliferations may  be the initial manifestation of NF1 or MEN
b.13
The clinical presentation of isolated neuroﬁbromatous lesions
f the intestines are myriad and are dependent upon the focal or
iffuse nature of the lesions, their location, their effect on gas-
rointestinal motility and their possible impingement on adjacent
tructures,13 resulting in abdominal pain, palpable masses, bleed-
ng due to necrosis or ulceration of the mucosa, obstruction due
o intussusception or extra-luminal pressure, diarrhoea, perfora-
ion, obstructive jaundice and obstruction of the pancreatic duct,3
mong others.
Intussusception is an unusual cause of bowel obstruction in
dults. It is more frequent in boys under the age of two, although
t can be encountered at any age.14,15 The aetiology and pathol-
gy of invagination in children and adults are different. Infantile
nvaginations constitute more than 80% of infantile bowel obstruc-
ion, and 90% of the cases do not indicate any aetiological cause or
hought to be caused by enlarged nodes associated with an aden-
viral infection.16,17 In contrast, adult invaginations are rare, and
onstitute 5% of all invaginations and less than 1% of all mechan-
cal bowel obstruction14–18 in addition, a demonstrable aetiology
s found in nearly 90% of cases in the adult population19 of which
ould be isolated intestinal neuroﬁbromas.
Radiologically, the differential diagnosis of single or multi-
le nodular neuroﬁbromatous lesions is wide and includes many
pithelial and stromal neoplasms as well as nodular lymphomas.13
et, diffuse intestinal ganglioneuromatosis may  mimic, radiologi-
ally, Crohn’s disease,6,20 intestinal lymphoma or carcinoid tumour
ith diffuse inﬁltration of the bowel wall.6
The endoscopic appearance of these lesions depends on the focal
r diffuse nature of the lesions. Most lesions can be approached
ndoscopically, and endoscopic biopsies are a mainstay of the
iagnosis. But as neuroﬁbromas arise deep to the epithelium, the
iopsies may  yield only unaffected overlying bowel mucosa or min-
mally diagnostic superﬁcial lesional tissue13 mainly when lesions
re small in size.
Macroscopically, these tumours are ﬁrm and solid in consis-
ency, and white to tan in colour. Haemorrhage and necrosis arePEN  ACCESS
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exceptional,  but superﬁcial ulceration has been reported13 in both
focal and diffuse entities.
In  view of the uncertain aetiology and diagnosis and high
incidence of malignancy (approaching 50%), the treatment of intus-
susception in adults is invariably surgical resection. However, the
extent of bowel resection and the manipulation of the intus-
suscepted bowel during reduction remain controversial.19,21,22 In
contrast to paediatric patients, where intussusception is primary
and benign, preoperative reduction with barium or air is not sug-
gested as a deﬁnite treatment for adults.19 The theoretical risks
of preliminary manipulation and reduction of an intussuscepted
bowel include (1) intraluminal seeding and venous tumour dis-
semination, (2) perforation and seeding of microorganisms and
tumour cells to the peritoneal cavity, and (3) increased risk of anas-
tomotic complications of the manipulated friable and edematous
bowel tissue.19,21 Moreover, reduction should not be attempted if
there are signs of inﬂammation or ischaemia of the bowel wall and
at age above 60 years.21 However, several others believe that the
risks are theoretical, and gentle reduction should be attempted in
selected cases to avoid unnecessary resection of healthy bowel.21
Endoscopic resection of colonic lipomatous polyps and laparo-
scopic resection of benign bowel tumours causing ileal and/or
ileocolic intussusception has a role in very selected settings,22
care must be taken during trocars insertion and insufﬂation spe-
cially in cases of intestinal dilatation in order to avoid bowel
injury.
So, the primary therapeutic option of isolated neuroﬁbroma-
tous proliferations of the intestines is surgical,6 depending on
the location and size of the lesions. For asymptomatic, inci-
dental ﬁndings during endoscopy, no further treatment may  be
required.13 Otherwise, resection of the lesions is dictated by
patient’s symptoms and operability. In all cases, a correct diagno-
sis has considerable implications for further management as the
bowel involvement could be the ﬁrst manifestation of neuroﬁbro-
matosis.
A similar case of an isolated ileal neuroﬁbroma has been
reported by Watanuki et al.23 in 1995. The patient presented,
however, with an ileocolic intussusception. Moreover, single or
multiple neuroﬁbromas have rarely been reported in literature.
These lesions were found in the soft palate, oesophagus, stomach,
gallbladder, common bile duct, small bowel and the mesentery,
colon and the anal canal with no evidence of associated systemic
disease.24
The presence of isolated neuroﬁbromas outside the GIT has also
been documented. These rare cases involved the kidney, spermatic
cord, nasal cavity, palatine tonsil, parapharyngeal space, larynx,
humerus, submandibular salivary gland, conjunctiva, retroperi-
toneal space, cranial ventricles and chest wall.
4. Conclusion
An isolated ileal neuroﬁbroma with no associated signs of
neuroﬁbromatosis or other relevant systemic disease is a rare
pathological entity. The clinical signiﬁcance of such a diagnosis lies
mainly in the need of further follow up of these patients as the
bowel involvement could be the ﬁrst manifestation of neuroﬁbro-
matosis type 1 or multiple endocrine neoplasia type 2b.
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